Foveal translocation with scleral imbrication in patients with myopic neovascular maculopathy
Section snippets
Methods
The records of 10 consecutive patients with myopic neovascular maculopathy who underwent foveal translocation with scleral imbrication between July 1998 and May 2000 at the Department of Ophthalmology, Niigata University Hospital, Niigata, Japan, were reviewed for this study.
Inclusion criteria were myopia 6.0 diopters or greater in refractive error (or axial length 26.5 mm or longer), subfoveal choroidal neovascularization, and preoperative best-corrected visual acuity of 20/100 or worse. None
Results
The age of the 10 patients in this study ranged from 33 to 74 years (mean, 54.8 ± 14.5 years). Of the 10 patients, nine were female and one was male. Follow-up ranged from 3 to 28 months (mean, 15.7 ± 8.2 months).
Of the 10 patients, two (patients 6 and 7) required a reoperation because of insufficient foveal displacement induced by the previous surgery. The details of one of these two patients (patient 7) are described in the case reports.
Postoperatively, the fovea was translocated by a
Case 1 (patient 1)
A 70-year-old woman with high myopia (RE: −7.0 diopters) presented with decreased vision and metamorphopsia in her right eye. The duration of her symptoms was uncertain. Best-corrected visual acuity was RE: 20/300 and LE: 20/40. On examination, the anterior segments were normal except for cortical cataracts in both eyes. Fluorescein and indocyanine green angiography of the right eye disclosed a well-defined subfoveal choroidal neovascularization surrounded with subretinal hemorrhage. Scanning
Discussion
Several studies attempted to define the natural history of choroidal neovascularization in degenerative myopia, but their results have been contradictory. It has been accepted that the choroidal neovascularization in degenerative myopia is usually self-limited. Avila and associates1 found a relatively favorable natural course of macular choroidal neovascularization. According to Hampton and associates,3 however, the natural course of choroidal neovascularization in degenerative myopia has a
References (25)
- et al.
Natural history of choroidal neovascularization in degenerative myopia
Ophthalmology
(1984) - et al.
Pathologic myopia and choroidal neovascularization
Am J Ophthalmol
(1981) - et al.
Visual prognosis of disciform degeneration in myopia
Ophthalmology
(1983) - et al.
Visual results after surgical removal of subfoveal choroidal neovascular membranes
Ophthalmology
(1994) - et al.
Translocation of the retina for management of subfoveal choroidal neovascularization Iexperimental studies in the rabbit eye
Am J Ophthalmol
(1998) - et al.
Translocation of the retina for management of subfoveal choroidal neovascularization IIa preliminary report in humans
Am J Ophthalmol
(1998) - et al.
Visual function after foveal translocation with scleral shortening in patients with myopic neovascular maculopathy
Am J Ophthalmol
(1998) - et al.
Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results
Ophthalmology
(1992) Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes
Am J Ophthalmol
(1994)- et al.
Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes
Am J Ophthalmol
(1996)
Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration
Am J Ophthalmol
Clinical observations in cyclodeviations
Ophthalmology
Cited by (13)
Choroidal neovascularization in pathological myopia
2012, Progress in Retinal and Eye ResearchPhotodynamic Therapy vs Limited Macular Translocation in the Management of Subfoveal Choroidal Neovascularization in Pathologic Myopia: A Two-year Study
2007, American Journal of OphthalmologyCitation Excerpt :The presence of prior laser scar in 44% of eyes, the larger size of the neovascular membrane, and the older age of patients may explain the result differences between the later and the current study. In 2001, Ichibe and associates12 reported an improvement by 3 lines or more in all 10 myopic eyes that were operated on and that had a follow-up of six months or more. In one of our previous reports comparing translocation to surgical removal of the CNV, the distribution of change in final visual acuity was in favor of translocation, with an improvement in vision by 3 lines or more in 50% of eyes after translocation vs 33% after surgical removal (P = .01).19
Pathologic myopia: Where are we now?
2002, American Journal of OphthalmologyCitation Excerpt :The mean preoperative visual acuity was 20/140 (range, 20/1000 to 20/50). The LMT surgical procedure performed was similar to that described in previous reports.53,54,57,62–64 Either scleral infolding or scleral outfolding was used to shorten the sclera.
Latrogenic diplopia
2014, International OphthalmologyAnti-vascular endothelial growth factor: The future treatment of choroidal neovascularization in pathologic myopia?
2013, Chinese Medical JournalIntravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia
2007, British Journal of Ophthalmology